Is Your Paper Ready for Molecular Systems Biology? How Editors Actually Decide

What Molecular Systems Biology is

Molecular Systems Biology (MSB) is EMBO's flagship systems biology journal, launched in 2005. It publishes ~150 papers per year, making it highly selective. The journal explicitly favors papers that model biological systems quantitatively and test predictions experimentally.

The editorial philosophy: biology is best understood as integrated systems. Papers must show a mechanism that connects components (genes, proteins, pathways) into a coherent system-level narrative. Gene lists alone don't qualify. Neither does pure computation without experimental validation.

The numbers that matter

Impact Factor: 6.2 (2024 JCR). Highest among systems biology journals. Stable and well-respected in computational and integrative biology.

Acceptance Rate: 12-15%. Among the most selective open-access journals. For comparison: PLOS Computational Biology ~25%, eLife ~15%, Science ~3%. MSB is more selective than most field-specific journals.

APC: $5,400. Expensive but expected for high-impact open-access publication. Zenodo deposit included.

Desk Rejection Rate: ~40%. So only ~9-12% of submissions that survive desk review get published. The initial filter is strict.

What triggers desk rejection at MSB

Papers rejected without review: single-target mechanism studies (too narrow); gene expression profiling without systems-level framework (descriptive, not integrative); purely computational predictions without experimental validation; incremental parameter refinements of existing models; papers where experimental data don't constrain the model predictions meaningfully.

If your paper identifies Gene X in Disease Y without showing how X connects to a network or system-level behavior, desk rejection is likely.

What reviewers prioritize

Systems-level insight (Does this reveal something about how the system works as a whole?); integration of diverse data types (genomics + proteomics + imaging, for example); quantitative models or predictions that are experimentally testable; experimental validation of key predictions; reproducibility and code/data availability (MSB strongly prefers public data).

Should you submit there?

Yes, if: you have a systems-level hypothesis you've tested with multiple integrated data types; you've built or significantly refined a quantitative model; experimental validation backs computational predictions; your work demonstrates unexpected system-level behavior.

Consider alternatives if: your work is a single-gene or single-pathway discovery; your computational analysis is thorough but lacks experimental follow-up; your novelty is incremental; eLife or PLOS Biology better fits your scope.

Decision cue

Before submitting: Can you draw a systems-level diagram that your paper explains? If not, MSB probably isn't the right venue. If yes, and your data support it, prepare for a rigorous review process.